93 related articles for article (PubMed ID: 10744131)
1. Ingestion of green tea rapidly decreases prostaglandin E2 levels in rectal mucosa in humans.
August DA; Landau J; Caputo D; Hong J; Lee MJ; Yang CS
Cancer Epidemiol Biomarkers Prev; 1999 Aug; 8(8):709-13. PubMed ID: 10744131
[TBL] [Abstract][Full Text] [Related]
2. Effect of subacute ibuprofen dosing on rectal mucosal prostaglandin E2 levels in healthy subjects with a history of resected polyps.
Chow HH; Earnest DL; Clark D; Mason-Liddil N; Kramer CB; Einspahr JG; Guillen-Rodriguez JM; Roe DJ; Malone W; Crowell JA; Alberts DS
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):351-6. PubMed ID: 10794478
[TBL] [Abstract][Full Text] [Related]
3. Levels of rectal mucosal polyamines and prostaglandin E2 predict ability of DFMO and sulindac to prevent colorectal adenoma.
Thompson PA; Wertheim BC; Zell JA; Chen WP; McLaren CE; LaFleur BJ; Meyskens FL; Gerner EW
Gastroenterology; 2010 Sep; 139(3):797-805, 805.e1. PubMed ID: 20538001
[TBL] [Abstract][Full Text] [Related]
4. Effects of piroxicam on prostaglandin E2 levels in rectal mucosa of adenomatous polyp patients: a randomized phase IIb trial.
Calaluce R; Earnest DL; Heddens D; Einspahr JG; Roe D; Bogert CL; Marshall JR; Alberts DS
Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1287-92. PubMed ID: 11142413
[TBL] [Abstract][Full Text] [Related]
5. Physical activity, body mass index, and prostaglandin E2 levels in rectal mucosa.
Martínez ME; Heddens D; Earnest DL; Bogert CL; Roe D; Einspahr J; Marshall JR; Alberts DS
J Natl Cancer Inst; 1999 Jun; 91(11):950-3. PubMed ID: 10359547
[TBL] [Abstract][Full Text] [Related]
6. Supplementation with Brazil nuts and green tea extract regulates targeted biomarkers related to colorectal cancer risk in humans.
Hu Y; McIntosh GH; Le Leu RK; Somashekar R; Meng XQ; Gopalsamy G; Bambaca L; McKinnon RA; Young GP
Br J Nutr; 2016 Dec; 116(11):1901-1911. PubMed ID: 27923410
[TBL] [Abstract][Full Text] [Related]
7. Colonic mucosal prostaglandin E2 and cyclooxygenase expression before and after low aspirin doses in subjects at high risk or at normal risk for colorectal cancer.
Krishnan K; Ruffin MT; Normolle D; Shureiqi I; Burney K; Bailey J; Peters-Golden M; Rock CL; Boland CR; Brenner DE
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):447-53. PubMed ID: 11352853
[TBL] [Abstract][Full Text] [Related]
8. Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2.
Pugh S; Thomas GA
Gut; 1994 May; 35(5):675-8. PubMed ID: 8200564
[TBL] [Abstract][Full Text] [Related]
9. Effect of aspirin on prostaglandin E2 formation and transforming growth factor alpha expression in human rectal mucosa from individuals with a history of adenomatous polyps of the colon.
Barnes CJ; Hamby-Mason RL; Hardman WE; Cameron IL; Speeg KV; Lee M
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):311-5. PubMed ID: 10207634
[TBL] [Abstract][Full Text] [Related]
10. Effect of aspirin on prostaglandin E2 and leukotriene B4 production in human colonic mucosa from cancer patients.
Frommel TO; Dyavanapalli M; Oldham T; Kazi N; Lietz H; Liao Y; Mobarhan S
Clin Cancer Res; 1997 Feb; 3(2):209-13. PubMed ID: 9815674
[TBL] [Abstract][Full Text] [Related]
11. Spectral biomarkers for chemoprevention of colonic neoplasia: a placebo-controlled double-blinded trial with aspirin.
Roy HK; Turzhitsky V; Wali R; Radosevich AJ; Jovanovic B; Della'Zanna G; Umar A; Rubin DT; Goldberg MJ; Bianchi L; De La Cruz M; Bogojevic A; Helenowski IB; Rodriguez L; Chatterton R; Skripkauskas S; Page K; Weber CR; Huang X; Richmond E; Bergan RC; Backman V
Gut; 2017 Feb; 66(2):285-292. PubMed ID: 26503631
[TBL] [Abstract][Full Text] [Related]
12. A dose-finding study of aspirin for chemoprevention utilizing rectal mucosal prostaglandin E(2) levels as a biomarker.
Sample D; Wargovich M; Fischer SM; Inamdar N; Schwartz P; Wang X; Do KA; Sinicrope FA
Cancer Epidemiol Biomarkers Prev; 2002 Mar; 11(3):275-9. PubMed ID: 11895877
[TBL] [Abstract][Full Text] [Related]
13. Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer.
Chell S; Kaidi A; Williams AC; Paraskeva C
Biochim Biophys Acta; 2006 Aug; 1766(1):104-19. PubMed ID: 16859832
[TBL] [Abstract][Full Text] [Related]
14. Analysis of plasma and urinary tea polyphenols in human subjects.
Lee MJ; Wang ZY; Li H; Chen L; Sun Y; Gobbo S; Balentine DA; Yang CS
Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):393-9. PubMed ID: 7655336
[TBL] [Abstract][Full Text] [Related]
15. Cancer chemoprevention by tea polyphenols.
Lin JK; Liang YC
Proc Natl Sci Counc Repub China B; 2000 Jan; 24(1):1-13. PubMed ID: 10786933
[TBL] [Abstract][Full Text] [Related]
16. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.
Chow HH; Cai Y; Alberts DS; Hakim I; Dorr R; Shahi F; Crowell JA; Yang CS; Hara Y
Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):53-8. PubMed ID: 11205489
[TBL] [Abstract][Full Text] [Related]
17. Measurement of prostaglandin E2 in rectal mucosa in human subjects: a method study.
Finley PR; Bogert CL; Alberts DS; Einspahr J; Earnest DL; Blackwell G; Girodias K
Cancer Epidemiol Biomarkers Prev; 1995; 4(3):239-44. PubMed ID: 7606198
[TBL] [Abstract][Full Text] [Related]
18. Two stages of cancer prevention with green tea.
Fujiki H
J Cancer Res Clin Oncol; 1999 Nov; 125(11):589-97. PubMed ID: 10541965
[TBL] [Abstract][Full Text] [Related]
19. Randomized clinical trial of brewed green and black tea in men with prostate cancer prior to prostatectomy.
Henning SM; Wang P; Said JW; Huang M; Grogan T; Elashoff D; Carpenter CL; Heber D; Aronson WJ
Prostate; 2015 Apr; 75(5):550-9. PubMed ID: 25545744
[TBL] [Abstract][Full Text] [Related]
20. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production.
Ireson C; Orr S; Jones DJ; Verschoyle R; Lim CK; Luo JL; Howells L; Plummer S; Jukes R; Williams M; Steward WP; Gescher A
Cancer Res; 2001 Feb; 61(3):1058-64. PubMed ID: 11221833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
